Skip to content

Clinical trials

Observational Carcinoma in Situ trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma in Situ Phase: Observational Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20131
20152
20161
20171
20202
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Children's Oncology Group1
Dana-Farber Cancer Institute1
Hiantis Srl1
Instituto Nacional de Salud Publica, Mexico1
National Institutes of Health Clinical Center (CC)1
Orlucent, Inc1
Shandong University1
Superior University1
The HIV Netherlands Australia Thailand Research Collaboration1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma in Situ11
Multiple Sclerosis2
Neoplasms2
Uterine Cervical Neoplasms2
Barrett Esophagus1
Breast Neoplasms1
Carcinoma, Intraductal, Noninfiltrating1
Carcinoma, Lobular1
Central Nervous System Neoplasms1
Desmoid Tumors1

Trials

Showing 51 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.